NO20040485L - Fremgangsmåte til fremstilling av amorf form av torsemid. - Google Patents

Fremgangsmåte til fremstilling av amorf form av torsemid.

Info

Publication number
NO20040485L
NO20040485L NO20040485A NO20040485A NO20040485L NO 20040485 L NO20040485 L NO 20040485L NO 20040485 A NO20040485 A NO 20040485A NO 20040485 A NO20040485 A NO 20040485A NO 20040485 L NO20040485 L NO 20040485L
Authority
NO
Norway
Prior art keywords
torsemide
preparation
amorphous form
amorphous
Prior art date
Application number
NO20040485A
Other languages
English (en)
Inventor
Yatendra Kumar
Om Dutt Tyagi
Nitin Maheshwari
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of NO20040485L publication Critical patent/NO20040485L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
NO20040485A 2001-08-03 2004-02-03 Fremgangsmåte til fremstilling av amorf form av torsemid. NO20040485L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN830DE2001 IN192178B (no) 2001-08-03 2001-08-03
PCT/IB2002/003013 WO2003014086A1 (en) 2001-08-03 2002-08-02 Process for the preparation of amorphous form of torsemide

Publications (1)

Publication Number Publication Date
NO20040485L true NO20040485L (no) 2004-04-02

Family

ID=11097098

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040485A NO20040485L (no) 2001-08-03 2004-02-03 Fremgangsmåte til fremstilling av amorf form av torsemid.

Country Status (9)

Country Link
US (1) US7002018B2 (no)
EP (1) EP1417172A4 (no)
JP (1) JP2005519862A (no)
EA (1) EA200400263A1 (no)
IN (1) IN192178B (no)
NO (1) NO20040485L (no)
PL (1) PL373892A1 (no)
WO (1) WO2003014086A1 (no)
ZA (1) ZA200401103B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7980900B2 (en) * 2004-05-14 2011-07-19 Commscope, Inc. Of North Carolina Next high frequency improvement by using frequency dependent effective capacitance
WO2013132511A1 (en) * 2012-03-09 2013-09-12 Hetero Research Foundation Novel polymorph of lurasidone hydrochloride
CN103694165B (zh) * 2013-11-12 2016-05-04 江苏正大清江制药有限公司 吉美嘧啶无定形固化物及制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US30633A (en) * 1860-11-13 Improvement in fire-escapes
US34580A (en) * 1862-03-04 Improvement in brick-machines
GB1477664A (en) 1974-04-17 1977-06-22 Christiaens Sa A Pyridine derivatives
DE3529529A1 (de) 1985-08-17 1987-02-19 Boehringer Mannheim Gmbh Verfahren zur herstellung einer stabilen modifikation von torasemid
HRP980532B1 (en) * 1998-10-02 2005-06-30 Pliva Novel crystalline torasemide modification
US5914336A (en) * 1998-06-02 1999-06-22 Boehringer Mannheim Gmbh Method of controlling the serum solubility of orally administered torasemide and composition relating thereto
US6166045A (en) * 1998-06-02 2000-12-26 Roche Diagnostics Gmbh Torasemide of modification III
CA2379322A1 (en) 1999-08-11 2001-02-15 Teva Pharmaceutical Industries Ltd. Torsemide polymorphs
HRP20000162B1 (en) 2000-03-20 2004-06-30 Pliva D D Amorphous torasemide modification
HRP20000328A2 (en) 2000-05-19 2002-02-28 Pliva Farmaceutska Ind Dionik Novel polymorph v of torasemide

Also Published As

Publication number Publication date
EP1417172A1 (en) 2004-05-12
US20040254223A1 (en) 2004-12-16
US7002018B2 (en) 2006-02-21
IN192178B (no) 2004-03-06
ZA200401103B (en) 2006-04-26
EA200400263A1 (ru) 2005-06-30
JP2005519862A (ja) 2005-07-07
PL373892A1 (en) 2005-09-19
EP1417172A4 (en) 2005-05-11
WO2003014086A1 (en) 2003-02-20

Similar Documents

Publication Publication Date Title
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20015156D0 (no) 5-pyridyl-1,3-Azol forbindelser, fremgangsmåte for produksjon av de samme og deres anvendelse
NL300305I1 (nl) Werkwijze voor de bereiding van gesubstitueerde octanoylamides.
NO20013943D0 (no) Fremgangsmate for fremstilling av Citalopram
NO20040027L (no) Fremgangsmate for fremstillingen av escitalopram
NO20040278L (no) Fremgangsmate for fremstilling av perindopril
NO20040482L (no) Fremgangsmåte til fremstilling av tolterodin.
NO20033433D0 (no) Fremgangsmåte for fremstilling av 2-(2-pyridylmetyl)sulfinyl- 1H-benzimidasol
NO20041200L (no) Fremgangsmate for fremstilling av citalopram.
NO20052471D0 (no) Fremgangsmate for fremstilling av 3-metyltiopropanal.
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
NO20035538D0 (no) Fremgangsmåte for fremstilling av zaleplon
NO20025423L (no) Fremgangsmate for fremstilling av Citalopram
NO20035586D0 (no) Fremgangsmåte for fremstilling av cykloheksanol-derivater
MXPA02006102A (es) Metodo para preparar compuestos bormodifluoroaceticos.
NO20035136D0 (no) Fremgangsmåte til fremstilling av imipenem
NO20021118D0 (no) Fremgangsmåte for fremstilling av citalopram
NO20030515D0 (no) Fremgangsmåte for fremstilling av dinapsolin
NO20044332L (no) Forbedret fremgangsmate for fremstilling av nevirapine
NO20040485L (no) Fremgangsmåte til fremstilling av amorf form av torsemid.
NO20026112L (no) Fremgangsmåte for fremstilling av mineralkunstgjödsel
NO20026113D0 (no) Fremgangsmåte for fremstilling av mineralkunstgjödsel
NO20035138D0 (no) Fremgangsmåte til fremstilling av amorft natriumsilastatin
MXPA03009210A (es) PROCEDIMIENTO PARA LA PREPARACIoN DE OXABISPIDINAS.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application